A double-blind controlled trial assessing the efficacy of anti-inflammatories on symptoms and cognition of adolescents with schizophrenia
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Symptom severity: Positive and Negative Syndrome Scale score
Timeframe: six weeks
Cognition: MATRICS Consensus Cognitive Battery (MCCB) scores
Timeframe: six weeks